EDX Medical Group Plc

LSE • Healthcare • Diagnostics & Research • Quote as of 10/27/2026 13:07

Company Profile

IndustryDiagnostics & Research

SectorHealthcare

ExchangeLSE

Market Capitalization36.67 mln

Float237 mln

Earnings Date12/21/2026

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-3.34

Reliable

Relative Strength

83 / 100

Strongly outperforming

Debt / Equity

0.04

Debt-free

Pre-Tax Margin

-1,767%

Severely loss-making

ROE

-329

Deeply negative

Business Description

EDX Medical Group Plc is a Cambridge-based company focused on creating medical diagnostic tests for conditions such as diabetes, obesity, and kidney, liver, and inflammatory disorders. Founded in 2021 and operating within the United Kingdom, the company was previously called TECC Capital PLC before adopting its current name in November 2022.

Key Fundamentals

EPS-1.00

ROE-329

ROIC-849

ROA-196

EBITDA, mln-5.52

EV / EBITDA-5.89

EV / EBIT-5.58

Revenue, mln0.33

EV / Revenue98.36

Quote Details

Last 8.01

Change -0.98 (-10.9%)

Open 8.90

Volume 10,474

Turnover 83,897

Average Volume 47,180

Financial Ratios

Pre-Tax Profit Margin-1,767

Current Ratio1.94

Price / Book17.50

Price / Tangible Book8.75

Debt / Equity0.04

Price / Sales87.50

Financial Strength

Altman Z-Score1.72

Piotroski F-Score 4 / 9

Beneish M-Score-3.34

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-11%	3 / 100
1 Month	-7.93%	16 / 100
2 Months	-32.12%	3 / 100